$RNGE
RANGE IMPACT, INC. Stock $rnge

$rnge Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224011906 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.910M	$6.878M	$19.35M
YoY Change	29.69%	159.95%	300.36%
Cost Of Revenue	$3.428M	$4.995M	$13.11M
YoY Change	44.91%	198.16%	281.26%
Gross Profit	$481.5K	$1.883M	$6.235M
YoY Change	-25.8%	94.01%	347.5%
Gross Profit Margin	12.32%	27.38%	32.23%
Selling, General & Admin	$943.9K	$1.603M	$4.022M
YoY Change	30.0%	83.03%	98.8%
% of Gross Profit	196.01%	85.11%	64.5%
Research & Development	$131.6K	$104.4K	$458.9K
YoY Change	23.98%	-19.98%	-2.53%
% of Gross Profit	27.34%	5.55%	7.36%
Depreciation & Amortization	$638.4K	$711.7K	$1.782M
YoY Change	80.26%	242.8%	350.41%
% of Gross Profit	132.58%	37.8%	28.57%
Operating Expenses	$1.076M	$1.707M	$4.480M
YoY Change	29.24%	69.67%	79.67%
Operating Profit	-$594.0K	$124.0K	$1.754M
YoY Change	224.19%	-585.17%	-259.42%
Interest Expense	$175.3K	-$259.0K	$505.9K
YoY Change	301.63%	902.24%	523.22%
% of Operating Profit		-208.82%	28.84%
Other Income/Expense, Net	-$157.2K		$1.377M
YoY Change	260.14%		4772.04%
Pretax Income	-$751.2K	-$83.02K	$3.131M
YoY Change	231.11%	35.21%	-392.03%
Income Tax			$0.00
% Of Pretax Income			0.0%
Net Earnings	-$751.1K	-$83.02K	$3.131M
YoY Change	231.11%	61.52%	-392.03%
Net Earnings / Revenue	-19.21%	-1.21%	16.18%
Basic Earnings Per Share	-$0.01		$0.04
Diluted Earnings Per Share	-$0.01		$0.04
COMMON SHARES
Basic Shares Outstanding	101.0M shares	89.69M shares	83.13M shares
Diluted Shares Outstanding	101.0M shares		83.13M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$667.7K	$2.177M	$2.177M
YoY Change	191.55%	392.08%	392.08%
Cash & Equivalents	$667.7K	$2.177M
Short-Term Investments
Other Short-Term Assets	$90.76K	$115.3K	$115.3K
YoY Change	10213.64%	13004.55%	13004.55%
Inventory
Prepaid Expenses	$90.76K	$115.3K
Receivables	$6.004M	$7.185M	$7.433M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.389M	$9.725M	$9.725M
YoY Change	404.88%	582.62%	582.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.66M	$13.30M	$13.30M
YoY Change	96.71%	120.03%	120.03%
Goodwill	$751.4K	$751.4K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$9.980K	$9.980K	$9.980K
YoY Change	12.26%	12.26%	12.26%
Total Long-Term Assets	$13.42M	$14.06M	$14.06M
YoY Change	86.51%	106.64%	106.64%
TOTAL ASSETS
Total Short-Term Assets	$7.389M	$9.725M	$9.725M
Total Long-Term Assets	$13.42M	$14.06M	$14.06M
Total Assets	$20.81M	$23.79M	$23.79M
YoY Change	140.3%	189.03%	189.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.706M	$3.714M	$3.714M
YoY Change	64.96%	1488.49%	1488.47%
Accrued Expenses	$71.67K	$101.3K	$101.3K
YoY Change
Deferred Revenue	$205.3K
YoY Change
Short-Term Debt	$2.400M	$2.400M	$2.400M
YoY Change	2300.0%
Long-Term Debt Due	$2.514M	$2.756M	$2.756M
YoY Change	145.16%	108.9%	108.9%
Total Short-Term Liabilities	$6.897M	$8.971M	$8.971M
YoY Change	219.35%	477.66%	477.66%
LONG-TERM LIABILITIES
Long-Term Debt	$5.096M	$5.250M	$5.250M
YoY Change	34.5%	40.45%	40.45%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$5.096M	$5.250M	$5.250M
YoY Change	34.5%	40.45%	40.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.897M	$8.971M	$8.971M
Total Long-Term Liabilities	$5.096M	$5.250M	$5.250M
Total Liabilities	$11.99M	$14.22M	$14.22M
YoY Change	101.61%	168.78%	168.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$47.83M	-$47.08M
YoY Change	-5.17%	-6.24%
Common Stock	$56.65M	$56.65M
YoY Change	6.59%	6.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.820M	$9.567M	$9.567M
YoY Change
Total Liabilities & Shareholders Equity	$20.81M	$23.79M	$23.79M
YoY Change	140.3%	189.03%	189.03%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$751.1K	-$83.02K	$3.131M
YoY Change	231.11%	61.52%	-392.03%
Depreciation, Depletion And Amortization	$638.4K	$711.7K	$1.782M
YoY Change	80.26%	242.8%	350.41%
Cash From Operating Activities	-$1.113M	-$636.1K	$438.6K
YoY Change	-264.7%	1704.99%	-172.65%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$16.28K	$7.163M
YoY Change	-100.0%	-99.64%	23.22%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$16.28K	-$7.163M
YoY Change		-99.64%	9.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$396.1K		$1.651M
YoY Change	-36.74%		495.2%
Cash From Financing Activities	-$396.1K	1.803M	$8.459M
YoY Change	177.12%	-53.66%	11.96%
NET CHANGE
Cash From Operating Activities	-$1.113M	-636.1K	$438.6K
Cash From Investing Activities		-16.28K	-$7.163M
Cash From Financing Activities	-$396.1K	1.803M	$8.459M
Net Change In Cash	-$1.509M	1.151M	$1.734M
YoY Change	607.33%	-261.04%	329.29%
FREE CASH FLOW
Cash From Operating Activities	-$1.113M	-$636.1K	$438.6K
Capital Expenditures	$0.00	$16.28K	$7.163M
Free Cash Flow	-$1.113M	-$652.4K	-$6.724M
YoY Change	1480.36%	-85.83%	4.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent		usd
CY2022	RNGE	Gain On Bargain Purchase GainOnBargainPurchase		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset		usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022	RNGE	Gain On Bargain Purchase GainOnBargainPurchase		usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset		usd
CY2023	RNGE	Increase Decrease In Gain On Loan Forgiveness IncreaseDecreaseInGainOnLoanForgiveness		usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2022	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings		usd
CY2022	RNGE	Payments To Long Term Debt Issued For Collins Building Acquisition PaymentsToLongTermDebtIssuedForCollinsBuildingAcquisition		usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1		usd
CY2023	RNGE	Forgiveness Of Ppp Loan ForgivenessOfPppLoan		usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent		usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent		usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P6Y
CY2023Q3	us-gaap	Business Combination Bargain Purchase Gain Recognized Statement Of Income Or Comprehensive Income Extensible Enumeration BusinessCombinationBargainPurchaseGainRecognizedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://rangeimpact.com/20231231#GainOnBargainPurchase
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther		usd
CY2023Q4	RNGE	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities		usd
CY2022Q4	RNGE	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities		usd
CY2023Q4	RNGE	Deferred Income Tax Liabilities Operating Lease Rightofuse Assets DeferredIncomeTaxLiabilitiesOperatingLeaseRightofuseAssets		usd
CY2022Q4	RNGE	Deferred Income Tax Liabilities Operating Lease Rightofuse Assets DeferredIncomeTaxLiabilitiesOperatingLeaseRightofuseAssets		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q1	us-gaap	Gross Profit GrossProfit		usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	6957607	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	101023485	shares
CY2023	dei	Auditor Firm AuditorFirmId	314
CY2023	dei	Auditor Name AuditorName	MEADEN & MOORE, LTD
CY2023	dei	Auditor Location AuditorLocation	Cleveland, Ohio
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2176800	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	442369	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7185411	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	981385	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	247310	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	115324	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	884	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9724845	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1424638	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13301902	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6045514	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9976	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8892	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6805827	usd
CY2022Q4	us-gaap	Assets Assets	8230465	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3714014	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	233808	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	13111497	usd
CY2023	us-gaap	Gross Profit GrossProfit	6234809	usd
CY2022	us-gaap	Gross Profit GrossProfit	1393252	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4021556	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2022882	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	458889	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	470803	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4480445	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2493685	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1754364	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1100433	usd
CY2023	RNGE	Gain On Bargain Purchase GainOnBargainPurchase	-1875150	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	109435	usd
CY2023	us-gaap	Interest Expense InterestExpense	505917	usd
CY2022	us-gaap	Interest Expense InterestExpense	81178	usd
CY2023	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	7458	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1376691	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28257	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3131055	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1072176	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83129637	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83129637	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	68112248	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68112248	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-381641	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3250000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	750000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	393260	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1072176	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2939443	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2939443	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3110000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	386530	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3131055	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3131055	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9567028	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9567028	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3131055	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1072176	usd
CY2023	RNGE	Gain On Bargain Purchase GainOnBargainPurchase	-1875150	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	386530	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	393260	usd
CY2023	us-gaap	Depreciation Depreciation	1781573	usd
CY2022	us-gaap	Depreciation Depreciation	395543	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6204026	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	91466	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	247310	usd
CY2022	RNGE	Increase Decrease In Gain On Loan Forgiveness IncreaseDecreaseInGainOnLoanForgiveness	109435	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	114440	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3480206	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-122304	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	101283	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	1084	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	200	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	438637	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-603778	usd
CY2023	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1118664	usd
CY2022	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	5813057	usd
CY2023	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	1000000	usd
CY2023	RNGE	Payments To Long Term Debt Issued For Collins Building Acquisition PaymentsToLongTermDebtIssuedForCollinsBuildingAcquisition	4035250	usd
CY2023	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	1008897	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	15827	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	750000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7162811	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6547230	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3110000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3250000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	4035250	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	564014	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5091177	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1650659	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	277328	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	158815	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2400000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-350000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8458605	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7555034	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1734431	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	404026	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	442369	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	38343	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2176800	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	442369	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	750000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	243365	usd
CY2022	RNGE	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	-109435	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zDJUH8AGDa2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zIATJz6umcd8">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19346306	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4832278	usd
CY2023Q4	us-gaap	Receivables From Customers ReceivablesFromCustomers	2100255	usd
CY2022Q4	us-gaap	Receivables From Customers ReceivablesFromCustomers	0	usd
CY2021Q4	us-gaap	Receivables From Customers ReceivablesFromCustomers	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	RNGE	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	425634	usd
CY2023Q4	RNGE	Estimated Earnings EstimatedEarnings	340528	usd
CY2023Q4	RNGE	Revenue Earned On Contracts In Progress RevenueEarnedOnContractsInProgress	766162	usd
CY2023Q4	RNGE	Contract Billings To Date ContractBillingsToDate	518852	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	247310	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	751421	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2297324	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	592300	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13301902	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6045514	usd
CY2023	us-gaap	Depreciation Depreciation	1781573	usd
CY2022	us-gaap	Depreciation Depreciation	395543	usd
CY2023Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P2Y
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	22450	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14705879	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31705879	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14705879	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31705879	shares
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segment
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment	6156000	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	554900	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	199500	usd
CY2023Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	6910400	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6882544	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.69
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2650000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.18
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	140000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.12
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9392544	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.54
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2050000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.20
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	50000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.62
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11392544	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.47
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11192544	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.48
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11392544	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	378030	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11392544	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11192544	shares
CY2022	RNGE	Gain On Loan Forgiveness GainOnLoanForgiveness	109435	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	mature between 2024 through 2028
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2024-11-30
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.01	pure
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2023	RNGE	Effective Income Tax Rate Reconciliation Federal And State Tax Rate EffectiveIncomeTaxRateReconciliationFederalAndStateTaxRate	-0.28	pure
CY2022	RNGE	Effective Income Tax Rate Reconciliation Federal And State Tax Rate EffectiveIncomeTaxRateReconciliationFederalAndStateTaxRate	-0.28	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.28	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.28	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4718000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6690000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	3506000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	3514000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	187000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	202000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	342000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	86000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	208000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8961000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10492000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6944000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9174000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2017000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1318000	usd
CY2023Q4	RNGE	Deferred Income Tax Liabilities Derivative Income DeferredIncomeTaxLiabilitiesDerivativeIncome	1108000	usd
CY2022Q4	RNGE	Deferred Income Tax Liabilities Derivative Income DeferredIncomeTaxLiabilitiesDerivativeIncome	1108000	usd
CY2023Q4	RNGE	Deferred Income Tax Liabilities Fixed Assets DeferredIncomeTaxLiabilitiesFixedAssets	909000	usd
CY2022Q4	RNGE	Deferred Income Tax Liabilities Fixed Assets DeferredIncomeTaxLiabilitiesFixedAssets	210000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2017000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1318000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2200000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	900000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	16900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	18300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	16600000	usd
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The Federal carryforwards generated prior to December 31, 2017 expire on various dates through 2037, and Federal carryforwards generated after December 31, 2017 do not expire but are limited to 80% utilization in a given period.
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	5	segment
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19346306	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	13111497	usd
CY2023	us-gaap	Gross Profit GrossProfit	6234809	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1754364	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3131055	usd
CY2023Q4	us-gaap	Assets Assets	23788144	usd
CY2023	us-gaap	Depreciation Depreciation	1781573	usd
CY2023	us-gaap	Interest Expense InterestExpense	505917	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2127561	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	3439026	usd
CY2022	us-gaap	Gross Profit GrossProfit	1393252	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1100433	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1072176	usd
CY2022Q4	us-gaap	Assets Assets	8230465	usd
CY2022	us-gaap	Depreciation Depreciation	395543	usd
CY2022	us-gaap	Interest Expense InterestExpense	81178	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5813057	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3014887	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3998267	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5455633	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6877519	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	649002	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	845101	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2857766	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	1882940	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-183223	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	153693	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1659871	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	124023	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	36762	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	3404175	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-83022	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	639359	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1547258	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2645661	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	64952	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	357783	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	970517	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-443671	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-423197	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-198002	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-35563	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-447974	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-443186	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-119616	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-61400	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	20566878	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	3137126	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5848298	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1235473	usd

Files In Submission

Name	View Source	Status
0001493152-24-011906-index-headers.html	Edgar Link	pending
0001493152-24-011906-index.html	Edgar Link	pending
0001493152-24-011906.txt	Edgar Link	pending
0001493152-24-011906-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rnge-20231231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rnge-20231231_def.xml	Edgar Link	unprocessable
rnge-20231231_lab.xml	Edgar Link	unprocessable
rnge-20231231_pre.xml	Edgar Link	unprocessable
rnge-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RNGE
RANGE IMPACT, INC. Stock $rnge

2024 Q1 Form 10-K Financial Statement

#000149315224011906 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNGE RANGE IMPACT, INC. Stock $rnge

2024 Q1 Form 10-K Financial Statement

#000149315224011906 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNGE
RANGE IMPACT, INC. Stock $rnge